Charles Allen
Vermögen: 7 Mio $ am 31.07.2026
Vermögen: 7 Mio $ am 31.07.2026
Charles W.
Allen is Executive Chairman & Chief Executive Officer at BTCS, Inc. since 2021 and Chief Executive Officer & Director at Global Bit Ventures, Inc. since 2018.
Former roles include Secretary, Treasurer & Director at Innovation1 Biotech, Inc. from 2022 to 2025; Independent Director at 60 Degrees Pharmaceuticals, Inc. from 2023 to 2026; Chief Financial Officer & Secretary at Pantheon China Acquisition Corp.
II and III from 2010 to 2012; Managing Director at Broadband Capital Management LLC, TriPoint Global Equities LLC, and RK Equity Capital Markets LLC; Field Engineer at EMCORE Corp.; and Associate at Akul Group, Inc. Education includes undergraduate studies at Lehigh University and an MBA from Mason School of Business of The College of William & Mary.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BTCS, INC. 13,75 % | 15.06.2026 | 6 844 033 ( 13,75 % ) | 7 Mio $ | 31.07.2026 |
| 02.07.2026 | 59 ( 0 % ) | 69 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BTCS INC. | Vorstandsvorsitzender | 05.02.2014 |
Global Bit Ventures, Inc.
Global Bit Ventures, Inc. Internet Software/ServicesTechnology Services Operates online trading platform for cryptocurrency | Vorstandsvorsitzender | 12.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 05.08.2026 |
| INNOVATION1 BIOTECH INC. | Direktor/Vorstandsmitglied | 15.01.2025 |
Pantheon China Acquisition Corp. II
Pantheon China Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finanzdirektor/CFO | 30.06.2012 |
Pantheon China Acquisition Corp. III
Pantheon China Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finanzdirektor/CFO | 30.06.2012 |
Broadband Capital Management LLC
Broadband Capital Management LLC Investment ManagersFinance Broadband Capital Management LLC is an active manager | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
EMCORE Corp.
EMCORE Corp. SemiconductorsElectronic Technology Manufactures mixed-signal optics products | Electronic Technology |
Broadband Capital Management LLC
Broadband Capital Management LLC Investment ManagersFinance Broadband Capital Management LLC is an active manager | Finance |
Pantheon China Acquisition Corp. II
Pantheon China Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Pantheon China Acquisition Corp. III
Pantheon China Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TriPoint Global Equities LLC
TriPoint Global Equities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
RK Equity Capital Markets LLC
RK Equity Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
BTCS, Inc.
BTCS, Inc. Regional BanksFinance Provides blockchain infrastructure services and develops data analytics dashboard | Finance |
Akul Group, Inc. | |
Mason School of Business of The College of William & Mary
Mason School of Business of The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovation1 Biotech, Inc.
Innovation1 Biotech, Inc. Internet RetailRetail Trade Sells consumer cannabidiol products through online | Retail Trade |
Global Bit Ventures, Inc.
Global Bit Ventures, Inc. Internet Software/ServicesTechnology Services Operates online trading platform for cryptocurrency | Technology Services |
60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen